Latest Director Resignation News

ACDC Metals has rapidly expanded its Mount Jackson project in Nevada, completing an airborne geophysical survey and staking additional claims to triple the project size. The company is progressing towards drilling with fresh capital raised and a board change announced.

Arovella Therapeutics undergoes a major board overhaul and CEO resignation following a shareholder push, as the company embarks on a strategic review of its cell therapy platform.

Augustus Minerals completed a key drilling campaign at its flagship Music Well project with assay results due shortly, while continuing to progress permitting and landowner engagement for its Papua New Guinea gold projects.

Canyon Resources has mobilised its surface miner at the Minim Martap Bauxite Project, with first production on track for Q2 2026 and full funding secured through a US$140 million credit facility and cash reserves. Leadership changes and logistics updates mark a pivotal quarter for the company.

TerraCom Limited announces the resignation of Managing Director Danny McCarthy effective 30 April 2026, with Chris Bourke appointed as interim CEO. McCarthy will support the transition until September 2026, while the Board confirms no changes to operational or strategic priorities.

NeuRizer Limited has secured a pivotal partnership with Reliance Industries, enabling it to resolve funding challenges and accelerate its Leigh Creek urea project. This collaboration marks a turning point for the company, allowing it to exit suspension and advance critical regulatory and operational milestones.

Bougainville Copper Limited reported a preliminary net loss of K16 million for 2025, with no dividend declared. The company faces strategic uncertainty following a shareholder dispute over its preferred mining partner and the passing of its CEO.

Energy Technologies Limited reported a $5.63 million net loss for the half-year ending December 2025, with revenue down 53% as the company restructures and refocuses on renewable energy markets. Significant debt refinancing and board changes mark a critical phase for the industrial cable manufacturer.

Papyrus Australia Limited reported a reduced half-year loss and marked a significant commercial milestone with a $4.2 million supply contract, advancing its transition from technology development to early-stage commercialisation.

WA Kaolin reported $2.7 million in sales for the December quarter, secured a $1.5 million working capital loan, and restructured $20.4 million of debt, while focusing on plant improvements and cost reductions to address negative margins.

Nyrada Inc. reported a $3.19 million loss for the half-year ending December 2025, while advancing its lead drug candidate Xolatryp® into Phase IIa clinical trials targeting heart attack treatment.

Touch Ventures Limited reported a $4.6 million net loss for 2025, driven by investment impairments and foreign exchange impacts, while appointing Gannet Capital as its new investment manager to revamp its portfolio strategy.